market is anticipated to experience strong growth, expanding from USD 1.19 billion in 2025 to USD 1.95 billion by 2031, representing a CAGR of 8.8% during the forecast period.

Diagnostic Ultrasound Devices market is set for robust growth, expanding from USD 12.15 billion in 2025 to USD 18.83 billion by 2031, representing a CAGR of 7.8% over the forecast period.

According to comprehensive industry analysis, the market is projected to reach USD 542.1 million by 2032, exhibiting a CAGR of 4.95% during the forecast period.

Precision medicine market was valued at USD 130,400 million in 2024 and is projected to grow to USD 256,430 million by 2031, reflecting a CAGR of 10.4% during the forecast period.

According to comprehensive industry analysis, the market is projected to grow from USD 1.45 billion in 2025 to USD 2.15 billion by 2032, exhibiting a CAGR of 5.1% during the forecast period.

Global Chancroid Testing market was valued at USD 78.5 million in 2024 and is projected to reach USD 112.3 million by 2032, registering a compound annual growth rate (CAGR) of 4.6% during the forecast period.

Global Intravascular Ultrasound (IVUS) market was valued at USD 375 million in 2024 and is expected to reach USD 537 million by 2032, registering a compound annual growth rate (CAGR) of 5.4% during the forecast period.

market, valued at USD 566 million in 2024, is projected to reach USD 674 million by 2031, expanding at a CAGR of 2.6% during the forecast period.

market is projected to reach USD 137 million by 2031, growing at a CAGR of 3.4% during the forecast period.

compound annual growth rate (CAGR) of 3.4% during the forecast period.